| Bioactivity | Apalutamide-d4 is a deuterium labeled Apalutamide. Apalutamide is a potent and competitive androgen receptor (AR) antagonist, binding AR with an IC50 of 16 nM[1]. | ||||||||||||
| Name | Apalutamide-d4 | ||||||||||||
| CAS | 1638885-65-0 | ||||||||||||
| Formula | C21H11D4F4N5O2S | ||||||||||||
| Molar Mass | 481.46 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Clegg NJ, et al. ARN-509: a novel antiandrogen for prostate cancer treatment. Cancer Res. 2012 Mar 15;72(6):1494-503. |
Apalutamide-d4
CAS: 1638885-65-0 F: C21H11D4F4N5O2S W: 481.46
Apalutamide-d4 is a deuterium labeled Apalutamide. Apalutamide is a potent and competitive androgen receptor (AR) antago
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.